Findings show dose reductions alter minimum treatment delivery in breast cancer, suggesting a need for balancing safety and dose intensity.
Early dosing decisions shaped subsequent chemotherapy delivery. Most patients who began at full dose maintained consistent dosing, whereas early reductions did not stave off subsequent changes, underscoring the need to balance safety with adequate dose intensity.
No takes yet. Share an insight, caveat, or question.
Monroy-Iglesias et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: